Online Home Base
Academician Zhao Jizong received Honorary Fellowship from Hong Kong College of Surgeons
Hybrid operation on complex cerebrovascular diseases reached world advanced level
CHANCE (Clopidogrel in High-risk patients with Acute Non-disabling Cerebrovascular Events)
＂The high risk non-disabling cerebrovascular disease and its key technologies for prevention and treatment＂ won the second prize of the 2016 National Science and Technology Progress Award
Professor Wang Yongjun's team of cerebrovascular disease precision medical research results published in JAMA
Professor Wang Yongjun's team in JAMA issued a document confirming multiple interventions to improve stroke quality
“Integrated Innovation and Application of Key Technologies in Diagnosis and Treatment of Brainstem Glioma” win the second prize of Beijing Science and Technology Progress Award in the year 2016.
An 《Acta Neuropathologica》 publication from Professor Liwei Zhang’s team discovered that the mutational profile of brainstem gliomas can be identified via sequencing cerebrospinal fluid-derived c
“Treatment Strategy and Application of Key Technologies in Auditory Protection and Reconstruction of Treating Acoustic Neuroma” win the second prize of National Science and Technology Progress Awar
Surgical Treatment of Cerebrovascular Malformations in the Proximal Functional Areas Has Reached the International Leading Level
“Key technology innovation and application for the diagnosis and treatment of gliomas” won the 2017 Second Prize of National Science and Technology Progress Award.
Professor Tao Jiang’s team invented a new targeted therapy for gliomas, which was elected as “China’s top ten progress of life science in 2018”.
“Key Technologies, System and Clinical Application of Deep Brain Stimulation System” Won the First Prize of State Scientific and Technological Progress Award（2018）
Science and Technology Transformation of the Center for Neurogenic Monogenic Diseases and
Research and Development of Artificial Intelligence Image Aided Diagnosis System 50 million conversion
RobEnt minimally invasive vascular interventional robot
Edaravone drug sublingual tablet results converted 150 million
@China National Clinical Research Center for Neurological Diseases | Technical Support：Beijing Zhinan Technology Company | Beijing Public Security:NO 330123004000099